Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Opioids
FDA ER-LA REMS Day 2 of the Drug Safety and Risk Management Advisory…
Day Two of the Joint Meeting of the Drug Safety and Risk Management Advisory Committee (DSaRM) and the Anesthetic and…
FDA ER-LA REMS Day One of Meeting of the Drug Safety and Risk Management…
The Food and Drug Administration (FDA) is hosting a two-day long Joint Meeting of the Drug Safety and Risk Management…
CME and the Opioid Crisis
Dramatic increases in death due to prescription opioid abuse has gained national attention. In the last month alone, the…
FDA Opinion on Proactive Response to Prescription Opioid Abuse
Opioid abuse has been in the news for the past few months, and it seems as though it will continue to be in the news for…
FDA Announces Labeling Changes for Immediate Release Opioid Medications
The United States Food and Drug Administration has announced new required class-wide safety labeling changes for…
House Oversight Committee: America’s Heroin and Opioid Abuse Epidemic
On the same day that the FDA issued black box warning to all immediate release opioids, the House Committee on Oversight…
CDC Releases Guidelines for Prescribing Opioids
The dramatic increase in overdose deaths due to opioids has been a major focus of political and medical leaders over the…